bioAffinity Technologies, Inc.
BIAF
$10.50
$1.5717.58%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 7.29% | -15.72% | 37.88% | -24.39% | -52.64% |
| Total Depreciation and Amortization | -46.20% | -7.44% | 9.08% | 0.18% | -26.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5,388.81% | -78.37% | -97.65% | 120.86% | 290.20% |
| Change in Net Operating Assets | -348.27% | -29.27% | 208.65% | -1,479.15% | -95.18% |
| Cash from Operations | 0.81% | -26.08% | -3.20% | 6.30% | -61.24% |
| Capital Expenditure | -1,478.95% | -- | -100.00% | 126.87% | 73.62% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,478.95% | -- | -100.00% | 126.87% | 73.62% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 44.22% | -11.06% | -347.56% | 125.81% | -19.97% |
| Issuance of Common Stock | -- | -- | -81.49% | 205.36% | 172.01% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -100.00% | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 75.08% | -- | -- |
| Cash from Financing | 2,313.00% | -108.84% | -85.66% | 209.49% | 192.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.05% | -174.84% | -117.76% | 1,817.45% | 154.21% |